[HTML][HTML] Advances in the antimicrobial treatment of osteomyelitis
C Zhong, Y Wu, H Lin, R Liu - Composites Part B: Engineering, 2023 - Elsevier
Osteomyelitis is a major complication of orthopedic diseases with high recurrence and
morbidity, along with long hospital stays and high medical costs. The conventional treatment …
morbidity, along with long hospital stays and high medical costs. The conventional treatment …
Antimicrobial Treatment of Pseudomonas aeruginosa Severe Sepsis
Pseudomonas aeruginosa is a pathogen often encountered in a healthcare setting. It has
consistently ranked among the most frequent pathogens seen in nosocomial infections …
consistently ranked among the most frequent pathogens seen in nosocomial infections …
A retrospective, observational study of 12 cases of expanded-access customized phage therapy: production, characteristics, and clinical outcomes
Background Antimicrobial resistance (AMR) is undermining modern medicine, a problem
compounded by bacterial adaptation to antibiotic pressures. Phages are viruses that infect …
compounded by bacterial adaptation to antibiotic pressures. Phages are viruses that infect …
Bacteriophage and bacterial susceptibility, resistance, and tolerance to antibiotics
Bacteriophages, viruses that infect and replicate within bacteria, impact bacterial responses
to antibiotics in complex ways. Recent studies using lytic bacteriophages to treat bacterial …
to antibiotics in complex ways. Recent studies using lytic bacteriophages to treat bacterial …
Last resort beta-lactam antibiotics for treatment of New-Delhi Metallo-Beta-Lactamase producing Enterobacterales and other Difficult-to-Treat Resistance in Gram …
R Larcher, P Laffont-Lozes, C Roger… - Frontiers in Cellular …, 2022 - frontiersin.org
Introduction Novel last resort beta-lactam antibiotics are now available for management of
infections due to New-Delhi Metallo-Beta-Lactamase (NDM) producing Enterobacterales …
infections due to New-Delhi Metallo-Beta-Lactamase (NDM) producing Enterobacterales …
Phage therapy as a novel therapeutic for the treatment of bone and joint infections
GA Suh, T Ferry, MP Abdel - Clinical Infectious Diseases, 2023 - academic.oup.com
Solutions for bone and joint infection (BJI) are needed where conventional treatments are
inadequate. Bacteriophages (phages) are naturally occurring viruses that infect bacteria and …
inadequate. Bacteriophages (phages) are naturally occurring viruses that infect bacteria and …
Optimized preparation pipeline for emergency phage therapy against Pseudomonas aeruginosa at Yale University
S Würstle, A Lee, KE Kortright, F Winzig, W An… - Scientific Reports, 2024 - nature.com
Bacteriophage therapy is one potential strategy to treat antimicrobial resistant or persistent
bacterial infections, and the year 2021 marked the centennial of Felix d'Hérelle's first …
bacterial infections, and the year 2021 marked the centennial of Felix d'Hérelle's first …
Engineering Phages to Fight Multidrug-Resistant Bacteria
Facing the global “superbug” crisis due to the emergence and selection for antibiotic
resistance, phages are among the most promising solutions. Fighting multidrug-resistant …
resistance, phages are among the most promising solutions. Fighting multidrug-resistant …
Refractory Pseudomonas aeruginosa infections treated with phage PASA16: A compassionate use case series
Background A growing number of compassionate phage therapy cases were reported in the
last decade, with a limited number of clinical trials conducted and few unsuccessful clinical …
last decade, with a limited number of clinical trials conducted and few unsuccessful clinical …
Human Complement Inhibits Myophages against Pseudomonas aeruginosa
JE Egido, SO Dekker, C Toner-Bartelds, C Lood… - Viruses, 2023 - mdpi.com
Therapeutic bacteriophages (phages) are primarily chosen based on their in vitro
bacteriolytic activity. Although anti-phage antibodies are known to inhibit phage infection …
bacteriolytic activity. Although anti-phage antibodies are known to inhibit phage infection …